Delivery Order SPE2DB22D3004-SPE2DB24FPQ95
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a major pharmaceutical distributor, a $4,128.52 firm-fixed-price delivery order contract (SPE2DB22D3004|SPE2DB24FRN07) for the supply of Tresiba FlexTouch 200 Unit/mL 3mL insulin pens. This order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables the government to efficiently procure a range of medical commodities...
- The Defense Logistics Agency awarded a delivery order valued at approximately $74,717 to AmerisourceBergen Drug Corp for the supply of Tresiba FlexTouch 200 unit/mL 3mL insulin pens. The contract, awarded on August 7, 2025, with an ultimate completion date of August 8, 2025, utilizes a firm fixed price structure and carries no set-aside designation. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded a $4,222.74 delivery order to AmerisourceBergen Drug Corp for Tresiba FlexTouch 200 unit/ml insulin pens (3ml). This contract, awarded on July 21, 2025, represents a firm fixed-price procurement with an ultimate completion date of July 22, 2025. The award was not set-aside and was competitively awarded through open competition. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform the work at...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract is for the delivery of Tresiba Flextouch 100 unit/ml 3ml insulin pens, with a potential value of $2,001.06 and a completion date of February 9, 2024. Amerisourcebergen Drug Corp is the prime contractor and holds an indefinite...
- The Defense Logistics Agency awarded a $1,384.20 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Tresiba FlexTouch 100 Unit/ML 3ML insulin pens. This is a non-set-aside contract with an ultimate completion date of August 13, 2025, and performance will occur at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The U.S. Defense Logistics Agency (DLA) awarded a $6,334.74 firm-fixed-price delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,556,926,723 units of Tresiba FlexTouch 200 unit/mL 3mL insulin medication. This delivery order is part of AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for $2,491.38 to supply Tresiba FlexTouch 200 unit/mL 3mL insulin pens. This is a firm fixed-price delivery order with an ultimate completion date of September 29, 2025, and represents a non-set-aside competitive award. The order will be fulfilled at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Tresiba FlexTouch 100 Unit/mL 3mL insulin pens, with a ceiling value of $1,582.33 and a firm fixed price structure. The contract was awarded on July 21, 2025, with an ultimate completion date of July 22, 2025, and represents a non-competitive, non-set-aside procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Tresiba Flextouch insulin pens. The $7,699.35 firm fixed price contract has an ultimate completion date of August 21, 2024. This order is part of a broader Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for delivering a wide range of medical...
- The Defense Logistics Agency (DLA) has awarded a delivery order contract to Amerisourcebergen Drug Corp Corporate Office Division, a major pharmaceutical distributor, for the supply of TRESIBA FLEXTOUCH 200 UNIT/ML 3ML insulin medication. The $18,948.75 firm-fixed-price contract has an ultimate completion date of October 10, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB24FPQ95Delivery Order
The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract for $2,001.55 to supply Tresiba Flextouch 200 unit/mL 3mL insulin pens. This delivery order was issued under an existing indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, which has a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This specific delivery order has an ultimate completion date of March 13, 2024. No set-aside designation was used for this contract.